Tolingin, Mary Joy .

HRN: 15-85-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2023
METRONIDAZOLE 500MG (TAB)
11/25/2023
12/02/2023
PO
500mg
TID X 7 Days
Thickly MSAF
Waiting Final Action 
11/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/25/2023
11/27/2023
IV
500mg
Q8hrs X 4 Doses
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: